Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer

Cancer-related cognitive decline (CRCD) is a clinically important problem and negatively affects daily functioning and quality of life. We conducted a pilot longitudinal study from pre- to post-chemotherapy in patients with breast cancer to assess changes in inflammation and cognition over time, as...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neuroimmunology 2022-01, Vol.362, p.577769-577769, Article 577769
Hauptverfasser:	Janelsins, Michelle C., Lei, Lianlian, Netherby-Winslow, Colleen, Kleckner, Amber S., Kerns, Sarah, Gilmore, Nikesha, Belcher, Elizabeth, Thompson, Bryan D., Werner, Zachary A., Hopkins, Judith O., Long, Joan, Cole, Sharon, Culakova, Eva
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Agents - adverse effects Breast Neoplasms - drug therapy cancer Cancer-related cognitive decline (CRCD) Chemotherapy Cognition Cognitive Dysfunction - chemically induced Cognitive Dysfunction - immunology Cohort Studies Cytokines Cytokines - blood Cytokines - immunology Female Humans Inflammation - chemically induced Inflammation - immunology Longitudinal Studies Middle Aged Pilot Projects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Cancer-related cognitive decline (CRCD) is a clinically important problem and negatively affects daily functioning and quality of life. We conducted a pilot longitudinal study from pre- to post-chemotherapy in patients with breast cancer to assess changes in inflammation and cognition over time, as well as the impact of baseline cytokine level on post-chemotherapy cognitive scores. We found that concentrations of IL-6, MCP-1, sTNFRI, and sTNFRII significantly increased in patients, while IL-1β significantly decreased (p
ISSN:	0165-5728 1872-8421
DOI:	10.1016/j.jneuroim.2021.577769